Partenaires

Un grand merci aux partenaires qui ont déjà confirmé leur soutien :


  1. ABBOTT DIABETES CARE
  2. ADVANCED ACCELERATOR APPLICATIONS
  3. ALERE
  4. AKCEA THERAPEUTICS
  5. AEGERION PHARMACEUTICALS
  6. BAYER
  7. BD MEDICAL
  8. ESAI
  9. H.A.C. PHARMA
  10. HRA
  11. INSULET
  12. IPSEN PHARMA
  13. LABORATOIRES GENEVRIER
  14. LILLY FRANCE
  15. MEDTRONIC
  16. MERCK
  17. NOVARTIS PHARMA
  18. NOVO NORDISK
  19. PFIZER
  20. ROCHE DIABETES CARE FRANCE
  21. SANDOZ
  22. SANOFI
  23. SECA
  24. SOCIETE FRANÇAISE D'ENDOCRINOLOGIE (SFE) & EUROPEAN SOCIETY OF ENDOCRINOLOGY (ECE)
  25. SERB
  26. SERVIER
  27. SIEMENS
  28. SHIRE
  29. SONOSCANNER
  30. THERMO FISHER DIAGNOSTICS
  31. UNI-PHARMA
  32. VITALAIRE
  33. YPSOMED SELFCARE SOLUTIONS
Et aux associations présentes :

  1. ACROMEGALES, PAS SEULEMENT
  2. ASSOCIATION DE PATIENTS PORTEURS DE TUMEURS ENDOCRINES (APTED)
  3. ASSOCIATION GRANDIR
  4. FILIERE FIRENDO
  5. HYPOPARATHYROIDISME FRANCE
  6. SURRENALES
  7. VIVRE SANS THYROIDE


AOS (Atout Organisation Science), en tant que PCO mandaté par SFE CONGRES pour l’organisation du 35ème Congrès de la Société Française d’Endocrinologie, adhère au Code d’Ethique Professionnelle de MedTech Europe (MedTech Europe Code of Ethical Business Practice).

Validation du Congrès SFE Nancy 2018 effectuée par CVS (Conference Vetting System) :

EthicalMedTech - CVS - Assessment decision:

We refer to your submission dated 24-04-2018 related to the EMT11279 - 35ème Congrès de la SFE starting on 12-09-2018 in Nancy, France (herewith referred to as the "Event"). You have requested that we provide you with our decision as to whether or not the event is compliant with the MedTech Europe Code of Ethical Business Practice.

We are pleased to inform you that following our assessment we have determined that the event is: COMPLIANT